Copyright Reports & Markets. All rights reserved.

Global Glyburide Sales Market Report 2021

Request for Sample of this report
Buy now

1 Glyburide Market Overview

  • 1.1 Glyburide Product Scope
  • 1.2 Glyburide Segment by Type
    • 1.2.1 Global Glyburide Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 1.25mg
    • 1.2.3 2.5mg
    • 1.2.4 5mg
  • 1.3 Glyburide Segment by Application
    • 1.3.1 Global Glyburide Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Pediatric Use
    • 1.3.3 Geriatric Use
    • 1.3.4 Others
  • 1.4 Glyburide Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Glyburide Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Glyburide Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Glyburide Price Trends (2016-2027)

2 Glyburide Estimates and Forecasts by Region

  • 2.1 Global Glyburide Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Glyburide Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Glyburide Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Glyburide Revenue Market Share by Region (2016-2021)
  • 2.3 Global Glyburide Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Glyburide Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Glyburide Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Glyburide Estimates and Projections (2016-2027)
    • 2.4.2 Europe Glyburide Estimates and Projections (2016-2027)
    • 2.4.3 China Glyburide Estimates and Projections (2016-2027)
    • 2.4.4 Japan Glyburide Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Glyburide Estimates and Projections (2016-2027)
    • 2.4.6 India Glyburide Estimates and Projections (2016-2027)

3 Global Glyburide Competition Landscape by Players

  • 3.1 Global Top Glyburide Players by Sales (2016-2021)
  • 3.2 Global Top Glyburide Players by Revenue (2016-2021)
  • 3.3 Global Glyburide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glyburide as of 2020)
  • 3.4 Global Glyburide Average Price by Company (2016-2021)
  • 3.5 Manufacturers Glyburide Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Glyburide Market Size by Type

  • 4.1 Global Glyburide Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Glyburide Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Glyburide Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Glyburide Price by Type (2016-2021)
  • 4.2 Global Glyburide Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Glyburide Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Glyburide Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Glyburide Price Forecast by Type (2022-2027)

5 Global Glyburide Market Size by Application

  • 5.1 Global Glyburide Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Glyburide Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Glyburide Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Glyburide Price by Application (2016-2021)
  • 5.2 Global Glyburide Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Glyburide Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Glyburide Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Glyburide Price Forecast by Application (2022-2027)

6 North America Glyburide Market Facts & Figures

  • 6.1 North America Glyburide Sales by Company
    • 6.1.1 North America Glyburide Sales by Company (2016-2021)
    • 6.1.2 North America Glyburide Revenue by Company (2016-2021)
  • 6.2 North America Glyburide Sales Breakdown by Type
    • 6.2.1 North America Glyburide Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Glyburide Sales Breakdown by Type (2022-2027)
  • 6.3 North America Glyburide Sales Breakdown by Application
    • 6.3.1 North America Glyburide Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Glyburide Sales Breakdown by Application (2022-2027)

7 Europe Glyburide Market Facts & Figures

  • 7.1 Europe Glyburide Sales by Company
    • 7.1.1 Europe Glyburide Sales by Company (2016-2021)
    • 7.1.2 Europe Glyburide Revenue by Company (2016-2021)
  • 7.2 Europe Glyburide Sales Breakdown by Type
    • 7.2.1 Europe Glyburide Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Glyburide Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Glyburide Sales Breakdown by Application
    • 7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)

8 China Glyburide Market Facts & Figures

  • 8.1 China Glyburide Sales by Company
    • 8.1.1 China Glyburide Sales by Company (2016-2021)
    • 8.1.2 China Glyburide Revenue by Company (2016-2021)
  • 8.2 China Glyburide Sales Breakdown by Type
    • 8.2.1 China Glyburide Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Glyburide Sales Breakdown by Type (2022-2027)
  • 8.3 China Glyburide Sales Breakdown by Application
    • 8.3.1 China 317 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 317 Sales Breakdown by Application (2022-2027)

9 Japan Glyburide Market Facts & Figures

  • 9.1 Japan Glyburide Sales by Company
    • 9.1.1 Japan Glyburide Sales by Company (2016-2021)
    • 9.1.2 Japan Glyburide Revenue by Company (2016-2021)
  • 9.2 Japan Glyburide Sales Breakdown by Type
    • 9.2.1 Japan Glyburide Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Glyburide Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Glyburide Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Glyburide Market Facts & Figures

  • 10.1 Southeast Asia Glyburide Sales by Company
    • 10.1.1 Southeast Asia Glyburide Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Glyburide Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Glyburide Sales Breakdown by Type
    • 10.2.1 Southeast Asia Glyburide Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Glyburide Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Glyburide Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Glyburide Market Facts & Figures

  • 11.1 India Glyburide Sales by Company
    • 11.1.1 India Glyburide Sales by Company (2016-2021)
    • 11.1.2 India Glyburide Revenue by Company (2016-2021)
  • 11.2 India Glyburide Sales Breakdown by Type
    • 11.2.1 India Glyburide Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Glyburide Sales Breakdown by Type (2022-2027)
  • 11.3 India Glyburide Sales Breakdown by Application
    • 11.3.1 India Glyburide Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Glyburide Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Glyburide Business

  • 12.1 Amneal Pharmaceuticals
    • 12.1.1 Amneal Pharmaceuticals Corporation Information
    • 12.1.2 Amneal Pharmaceuticals Business Overview
    • 12.1.3 Amneal Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Amneal Pharmaceuticals Glyburide Products Offered
    • 12.1.5 Amneal Pharmaceuticals Recent Development
  • 12.2 Sanofi Aventis
    • 12.2.1 Sanofi Aventis Corporation Information
    • 12.2.2 Sanofi Aventis Business Overview
    • 12.2.3 Sanofi Aventis Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Sanofi Aventis Glyburide Products Offered
    • 12.2.5 Sanofi Aventis Recent Development
  • 12.3 Jisheng Medicine
    • 12.3.1 Jisheng Medicine Corporation Information
    • 12.3.2 Jisheng Medicine Business Overview
    • 12.3.3 Jisheng Medicine Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Jisheng Medicine Glyburide Products Offered
    • 12.3.5 Jisheng Medicine Recent Development
  • 12.4 Double Whale Pharmaceutical
    • 12.4.1 Double Whale Pharmaceutical Corporation Information
    • 12.4.2 Double Whale Pharmaceutical Business Overview
    • 12.4.3 Double Whale Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Double Whale Pharmaceutical Glyburide Products Offered
    • 12.4.5 Double Whale Pharmaceutical Recent Development
  • 12.5 Bohai Pharmaceutical
    • 12.5.1 Bohai Pharmaceutical Corporation Information
    • 12.5.2 Bohai Pharmaceutical Business Overview
    • 12.5.3 Bohai Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Bohai Pharmaceutical Glyburide Products Offered
    • 12.5.5 Bohai Pharmaceutical Recent Development
  • 12.6 Sunlight Pharmaceutical
    • 12.6.1 Sunlight Pharmaceutical Corporation Information
    • 12.6.2 Sunlight Pharmaceutical Business Overview
    • 12.6.3 Sunlight Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Sunlight Pharmaceutical Glyburide Products Offered
    • 12.6.5 Sunlight Pharmaceutical Recent Development
  • 12.7 Shapuaisi Pharma
    • 12.7.1 Shapuaisi Pharma Corporation Information
    • 12.7.2 Shapuaisi Pharma Business Overview
    • 12.7.3 Shapuaisi Pharma Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Shapuaisi Pharma Glyburide Products Offered
    • 12.7.5 Shapuaisi Pharma Recent Development
  • 12.8 CR Sanjiu
    • 12.8.1 CR Sanjiu Corporation Information
    • 12.8.2 CR Sanjiu Business Overview
    • 12.8.3 CR Sanjiu Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 CR Sanjiu Glyburide Products Offered
    • 12.8.5 CR Sanjiu Recent Development
  • 12.9 Physicians Total Care
    • 12.9.1 Physicians Total Care Corporation Information
    • 12.9.2 Physicians Total Care Business Overview
    • 12.9.3 Physicians Total Care Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Physicians Total Care Glyburide Products Offered
    • 12.9.5 Physicians Total Care Recent Development
  • 12.10 Hoechst Canada
    • 12.10.1 Hoechst Canada Corporation Information
    • 12.10.2 Hoechst Canada Business Overview
    • 12.10.3 Hoechst Canada Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Hoechst Canada Glyburide Products Offered
    • 12.10.5 Hoechst Canada Recent Development
  • 12.11 Apotex Corporation
    • 12.11.1 Apotex Corporation Corporation Information
    • 12.11.2 Apotex Corporation Business Overview
    • 12.11.3 Apotex Corporation Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Apotex Corporation Glyburide Products Offered
    • 12.11.5 Apotex Corporation Recent Development
  • 12.12 Avanstra
    • 12.12.1 Avanstra Corporation Information
    • 12.12.2 Avanstra Business Overview
    • 12.12.3 Avanstra Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Avanstra Glyburide Products Offered
    • 12.12.5 Avanstra Recent Development
  • 12.13 Dominion Pharmacal
    • 12.13.1 Dominion Pharmacal Corporation Information
    • 12.13.2 Dominion Pharmacal Business Overview
    • 12.13.3 Dominion Pharmacal Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Dominion Pharmacal Glyburide Products Offered
    • 12.13.5 Dominion Pharmacal Recent Development
  • 12.14 Hikma Pharmaceuticals
    • 12.14.1 Hikma Pharmaceuticals Corporation Information
    • 12.14.2 Hikma Pharmaceuticals Business Overview
    • 12.14.3 Hikma Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 Hikma Pharmaceuticals Glyburide Products Offered
    • 12.14.5 Hikma Pharmaceuticals Recent Development
  • 12.15 Cadila Pharmaceuticals
    • 12.15.1 Cadila Pharmaceuticals Corporation Information
    • 12.15.2 Cadila Pharmaceuticals Business Overview
    • 12.15.3 Cadila Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Cadila Pharmaceuticals Glyburide Products Offered
    • 12.15.5 Cadila Pharmaceuticals Recent Development
  • 12.16 Novartis
    • 12.16.1 Novartis Corporation Information
    • 12.16.2 Novartis Business Overview
    • 12.16.3 Novartis Glyburide Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Novartis Glyburide Products Offered
    • 12.16.5 Novartis Recent Development

13 Glyburide Manufacturing Cost Analysis

  • 13.1 Glyburide Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Glyburide
  • 13.4 Glyburide Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Glyburide Distributors List
  • 14.3 Glyburide Customers

15 Market Dynamics

  • 15.1 Glyburide Market Trends
  • 15.2 Glyburide Drivers
  • 15.3 Glyburide Market Challenges
  • 15.4 Glyburide Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Glyburide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glyburide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    1.25mg
    2.5mg
    5mg

    Segment by Application
    Pediatric Use
    Geriatric Use
    Others

    The Glyburide market is analysed and market size information is provided by regions (countries). Segment by Application, the Glyburide market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Amneal Pharmaceuticals
    Sanofi Aventis
    Jisheng Medicine
    Double Whale Pharmaceutical
    Bohai Pharmaceutical
    Sunlight Pharmaceutical
    Shapuaisi Pharma
    CR Sanjiu
    Physicians Total Care
    Hoechst Canada
    Apotex Corporation
    Avanstra
    Dominion Pharmacal
    Hikma Pharmaceuticals
    Cadila Pharmaceuticals
    Novartis

    Buy now